You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Valeant Pharms North Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for VALEANT PHARMS NORTH, and what generic and branded alternatives to VALEANT PHARMS NORTH drugs are available?

VALEANT PHARMS NORTH has fourteen approved drugs.

Summary for Valeant Pharms North

US Patents:	0
Tradenames:	11
Ingredients:	10
NDAs:	14

Drugs and US Patents for Valeant Pharms North

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Valeant Pharms North	CARAC	fluorouracil	CREAM;TOPICAL	020985-001	Oct 27, 2000		RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
Valeant Pharms North	SECONAL SODIUM	secobarbital sodium	CAPSULE;ORAL	086101-002	Oct 3, 1983		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Valeant Pharms North	VENLAFAXINE HYDROCHLORIDE	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	090071-002	Apr 15, 2011	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Valeant Pharms North	SECONAL SODIUM	secobarbital sodium	CAPSULE;ORAL	086101-001	Oct 3, 1983		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Valeant Pharms North	DILTIAZEM HYDROCHLORIDE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	075116-002	Dec 23, 1999	AB3	RX	No	No		⤷ Sign Up				⤷ Sign Up
Valeant Pharms North	NIFEDIPINE	nifedipine	TABLET, EXTENDED RELEASE;ORAL	075289-001	Sep 27, 2000	AB2	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Valeant Pharms North

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Valeant Pharms North	DERMATOP	prednicarbate	OINTMENT;TOPICAL	019568-001	Sep 23, 1991	4,242,334	⤷ Sign Up
Valeant Pharms North	CARAC	fluorouracil	CREAM;TOPICAL	020985-001	Oct 27, 2000	4,690,825	⤷ Sign Up
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	021108-001	Aug 31, 2000	6,531,141	⤷ Sign Up
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	021108-001	Aug 31, 2000	RE36068	⤷ Sign Up
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	019963-001	Dec 29, 1995	4,877,805	⤷ Sign Up
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	019963-001	Dec 29, 1995	4,603,146	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for VALEANT PHARMS NORTH drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Cream	0.5%	➤ Subscribe	2011-07-29

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.